This book critically examines the intersection of intellectual property rights, international trade law, and public health frameworks in achieving universal healthcare. It analyses TRIPS obligations, compulsory licensing, patent protection for pharmaceuticals, and access to medicines. The author evaluates global policy debates and the balance between innovation incentives and public welfare. Combining legal doctrine with socio-economic insights, the book is valuable for policymakers, researchers, healthcare professionals, and IP law scholars.







Reviews
There are no reviews yet.